Dysfunctional Mitochondria in Microglia Drive Cognitive Aging and Neurodegeneration via cGAS-STING

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Mitochondrial dysfunction is linked to metabolic issues in immune cells, contributing to age-related brain disorders.
• The precise role of microglial mitochondrial dysfunction in initiating neurological decline is not fully understood.

Purpose of the Study:

• To investigate how mitochondrial dysfunction in microglia impacts metabolic regulation, cognitive aging, and neurodegeneration.
• To elucidate the molecular mechanisms, including the cGAS-STING pathway, involved in microglial dysfunction-induced neuroinflammation.

Main Methods:

• Conditional knockout of mitochondrial transcription factor A in adult mice to induce microglial mitochondrial dysfunction.
• Single-cell RNA sequencing to analyze microglial states and neuroinflammatory profiles.
• Assessment of cognitive function and neurodegeneration markers.
• Pharmacological interventions targeting metabolic homeostasis and the cGAS-STING pathway.

Main Results:

• Mitochondrial dysfunction in microglia triggers metabolic dysregulation, cognitive aging, and neurodegeneration in mice.
• This dysfunction drives microglia towards neuroinflammatory states, initiating broader pathological cascades.
• Activation of the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway by mitochondrial dysfunction contributes to neuroinflammation and inflammaging.
• Combined metabolic and cGAS-STING inhibition partially reverses age-related neurological deficits.

Conclusions:

• Mitochondrial dysfunction in microglia is a key initiator of cognitive aging and neurodegeneration.
• The cGAS-STING pathway is a critical mediator of microglial dysfunction-induced neuroinflammation.
• Targeting microglial metabolism and the cGAS-STING pathway holds therapeutic potential for age-associated neurological diseases.